Evercore ISI downgraded Procter & Gamble to In Line from Outperform with a price target of $170, down from $190. Evercore expects a fiscal 2026 outlook with a “low but broad range” of scenarios to be issued on July 29 when Procter & Gamble reports Q4 results, the analyst tells investors in a research note. Macro pressures are transient, but the firm’s concern lies in adverse shifts in retail channels that challenge Procter’s growth potential, and could cap Procter’s sales growth below the 4% needed to drive operating leverage, the firm says.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Ex-Dividend Date Nearing for These 10 Stocks – Week of July 14, 2025
- Salesforce (NYSE:CRM) Board Gains AI Power with Chang and Kirk Appointments
- Procter & Gamble Reports 5% Increase in Net Sales
- Procter & Gamble Appoints Craig Arnold to Board
- PEP, KHC, CAG Could Be Set to Sack Thousands of Workers, Warns Analyst